Wednesday, 26 August 2026European Markets

OREGE Stock Over 22% Down In The Last 10 Sessions

Loading stream...

(vianews) - shares of orege (cac 40: orege.pa) dropped by a staggering 22.08% in 10 sessions from €0.39 to €0.30 at 05:05 est on wednesday, after five sequential sessions in a row of losses. cac 40 is jumping 0.47% to €7,533.63, following the last session's upward trend.

orege's last close was €0.30, 64.02% below its 52-week high of €0.82.

about orege

orege société anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in france, the united states, japan, germany, and the united kingdom. the company offers slg solution for conditioning, treating, and recovering municipal and industrial sludge; slg-f, a combination of slg conditioning solution; and flosep for sludge separation and thickening tool. it also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process line optimization services. the company was incorporated in 2005 and is headquartered in voisins-le-bretonneux, france. orege société anonyme is a subsidiary of eren groupe sa.

earnings per share

as for profitability, orege has a trailing twelve months eps of €-0.09.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, orege's stock is considered to be overbought (>=80).

revenue growth

year-on-year quarterly revenue growth grew by 36.5%, now sitting on 2.55m for the twelve trailing months.

yearly top and bottom value

orege's stock is valued at €0.30 at 05:05 est, under its 52-week low of €0.32.

moving average

orege's value is way below its 50-day moving average of €0.41 and way below its 200-day moving average of €0.56.

more news about orege (orege.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com